Skip to main content
SpringerLink
Log in

Pharma industry R&D proves valuable to Europe

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EFPIA.2008 Edition of EFPIA's “Pharmaceutical Industry in Figures“ shows Pharma at 19% of Global Business R&D Expenditure. Media Release: 19 Jun 2008. Available from: URL: http://www.efpia.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharma industry R&D proves valuable to Europe. Pharmacoecon. Outcomes News 556, 9 (2008). https://doi.org/10.2165/00151234-200805560-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805560-00028

Keywords

Search

Navigation